Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies

Overview of attention for article published in Frontiers in Pharmacology, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,859 followers.

RT @NephroSeeker: @Elena_Cervants 🛑#Flozins - contraindicated in pregnancy and lactation- data coming from animal studies ⁉️2013 FDA repo…

16 Nov 2022

Reply Repost Favourite

@Elena_Cervants 🛑#Flozins - contraindicated in pregnancy and lactation- data coming from animal studies ⁉️2013 FDA report showed 8 women continued SGLT2i during pregnancy -> outcomes👇 https://t.co/EbAdeJzX0e 🐁Empa ameliorates preeclampsia in murine

16 Nov 2022

Reply Repost Favourite

How can Luminex FlowSight improve your research? Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies https://t.co/ioudUsKkYC #WEareBIOCOM http

28 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.